ir.auxilium.com

ir.atossagenetics.com

Atossa Genetics, Inc. (ATOS)

Atossa Genetics, Inc., The Breast Health Company™, based in Seattle, WA, is focused on improving breast health through the commercialization of patented medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc. (NRLBH), patented tests. The NRLBH is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, Washington. Aug 6, 2015. Jun 30, 2015. Sign up for email alerts. Be the first to receive breaking news. Mr Youmans br...

ir.atricure.com

Investor Overview | Atricure

Skip to main content. Soft Tissue Dissection System. Left Atrial Appendage Exclusion Devices. AtriCure Product Image Gallery. AtriCure, Inc. at Canaccord 35th Annual Growth Conference. 160;at 1:00 pm ET. Q2 2015 AtriCure, Inc. Earnings Conference Call. 160;at 4:30 pm ET. 160;  0.21. 08/07/15 4:00 pm ET. Minimum 20 minute delay. Q1 Earnings Call Transcript. AtriCure Analyst Day Presentation. AtriCure Reports Second Quarter 2015 Financial Results and Updates 2015 Outlook. Revenue of $32.6 million up 22...

ir.atwd.com

Corporate Information | Atwood Oceanics

Why Work at Atwood. News and Market Information. Why Work at Atwood. News and Market Information. Corporate Profile / Risk Factors. News and Market Information. As of August 14, 2015 -. Minimum 20 minute delay. Atwood Oceanics Fiscal 2015 Third Quarter Earnings Conference Call. Thursday, July 30, 2015. Current Fleet Contract Status. ATWOOD OCEANICS ANNOUNCES FISCAL 2015 THIRD QUARTER EARNINGS. Atwood Oceanics Announces Fiscal 2015 Third Quarter Earnings Conference Call. Atwood Oceanics Announces Fiscal 2...

ir.aurismedical.com

Investor Relations - Auris Medical : development of novel pharmaceutical therapies to prevent or treat severe inner ear disorders like tinnitus and hearing loss

We at Auris Medical are dedicated to developing novel pharmaceutical therapies to protect hearing and to silence tinnitus. Auris Medical is the leading pioneer in the emerging field of cochlear (inner ear) therapies. We have two projects in advanced clinical development:. AM-101 for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. Auris Medical to Announce Second Quarter 2015 Financial Results and Host Conference Call on Wednesday, August 19, 2015.

ir.autopartscat.com

International Radiators

To obtain a login, please contact us at: info@internationalradiators.be.

ir.auxilium.com

Investor Overview - Investors - Auxilium

On January 29, 2015, Endo International plc (NASDAQ: ENDP) (TSX: ENL) completed the acquisition of Auxilium Pharmaceuticals, Inc., creating a leading global specialty healthcare company focused on improving patients’ lives while creating shareholder value. For Endo Investor information, visit http:/ www.endo.com/investors/overview.

ir.avalancheinternationalcorp.com

Avalanche International, Corp. (AVLP)

Smith Ramsay Premium Vape Liquid. Smith Ramsay Premium Vape Liquid. Avalanche International Issues Investor Update on J.S. Technologies, Inc. Aug 11, 2015. Sign up for email alerts. Be the first to receive breaking news. May 31, 2015. Slide" data-cycle-swipe="true" data-cycle-timeout=0 data-cycle-log="false". Philip E. Mansour. Chief Executive Officer, President and Director. Slide" data-cycle-swipe="true" data-cycle-timeout=0 data-cycle-log="false". Milton C. Ault, III. Philip E. Mansour. Since 2007, Mr...

ir.avanir.com

Investors | Avanir Pharmaceuticals

Skip to main content. Environmental, Health and Safety. Orange County, CA. Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on. View all Press Releases. Avanir Pharmaceuticals Announces New Findings from Dementia/Alzheimer's Disease Cohort of PRISM II Study at Al. Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study. Avanir Pharmaceuticals Announces Publication of Positive Phase IIIb Results from AVP-825 Head-to-Head COMPASS.

ir.avid.com

Investor Relations | Avid

Avid creates the digital audio and video technology used to make the most listened to, most watched and most loved media in the world - from the most prestigious and award-winning feature films, music recordings, television shows, live concert tours and news broadcasts, to music and movies made at home. Mar 29, 2018. Quincy Media Deploys Avid's Story-centric TV News Workflow Across 14 U.S. Markets. Mar 27, 2018. Avid Technology to Present at the Sidoti Spring 2018 Conference. View all press releases.

ir.avigilon.com

Avigilon - Investor Relations

Investor Events and Presentations. August 05, 2015. Avigilon Promotes James Henderson to Senior Vice President of Global Sales. July 29, 2015. Avigilon Corporation Reports Record Second Quarter 2015 Results. July 15, 2015. Avigilon Corporation to Host Second Quarter 2015 Investor Conference Call on July 29, 2015. June 25, 2015. Avigilon Appoints Ric Leong as Chief Financial Officer and Announces Results of Annual General and Special Meeting. June 16, 2015. Q2 2015 Quarterly Report (PDF 336 KB.

ir.avisbudgetgroup.com

Avis Budget - Investor Relations

Mar 21, 2018. Avis Budget Group Files Preliminary Proxy Materials. Feb 21, 2018. Avis Budget Group Reports Fourth Quarter and Full-Year 2017 Results. Feb 15, 2018. Avis Budget Group Comments on SRS Investment Management's Nomination of Directors. See more company news. Investor Presentation- March 2018. File Size: 2.1 MB. Investor Presentation- November 2017. File Size: 2.1 MB. Feb 22, 2018. At 8:30 AM ET. Q4 2017 Avis Budget Group Inc Earnings Conference Call. Nov 15, 2017. At 9:10 AM ET. Apr 3, 2017.